Skip to main content

Benjamin Catanese

Medical Instructor in the Department of Medicine
Medicine, Nephrology
300 W. Morgan Street, Office 821, Durham, NC 27701

Scholarly Works


Cardiovascular Outcomes among New Users of GLP-1 Receptor Agonists Compared with DPP-4 Inhibitors and Sulfonylureas in Kidney Failure.

Journal article J Am Soc Nephrol · March 12, 2026 KEY POINTS: Glucagon-like peptide-1 receptor agonists are increasingly used in patients with kidney failure despite trial exclusion. Initiation was associated with a 13% lower risk of cardiovascular events and 17% lower mortality versus dipeptidyl peptidas ... Full text Link to item Cite

Frailty in Focus: A Scoping Review of Frailty Instruments from the Kidney Disease Aging Research Collaborative.

Journal article Clin J Am Soc Nephrol · January 21, 2026 KEY POINTS: The clinical frailty scale has the strongest psychometric validity in kidney disease apart from the physical frailty phenotype. Existing frailty instruments have strong predictive validity for mortality and hospitalizations across kidney diseas ... Full text Link to item Cite

Cardiac Arrest in Outpatient Hemodialysis Units: A National Cross-Sectional Survey of Dialysis Technicians.

Journal article Am J Kidney Dis · July 2025 RATIONALE & OBJECTIVE: Cardiac arrest is the leading cause of death for hemodialysis patients and often occurs within outpatient dialysis units. Approximately one-fifth of dialysis unit resuscitations are not initiated until emergency medical service perso ... Full text Link to item Cite

Abstract 4139027: Glucagon-like Peptide-1 Receptor Agonist Use and Cardiac Outcomes in Patients with End Stage Kidney Disease

Conference Circulation · November 12, 2024 Background: Despite the substantial cardiovascular (CV) risk experienced by people with end-stage kidney disease (ESKD), few medications improve CV outcomes in this population. Glucagon-like peptide-1 ... Full text Cite

Point-of-Care Kidney and Genitourinary Ultrasound in Adults: Image Acquisition.

Journal article J Vis Exp · June 21, 2024 A range of conditions involving the kidneys and urinary bladder can cause organ-threatening complications that are preventable if diagnosed promptly with diagnostic imaging. Common imaging modalities include either computed tomography or diagnostic ultraso ... Full text Link to item Cite

FROM SOIL TO THE PERITONEUM: FUNGAL PERITONITIS WITH PAECILOMYCES VARIOTII

Conference AMERICAN JOURNAL OF KIDNEY DISEASES · April 2023 Link to item Cite

A pilot study to evaluate the safety and efficacy of treprostinil in the treatment of calcinosis in systemic sclerosis.

Journal article Rheumatology (Oxford) · May 30, 2022 OBJECTIVES: We evaluated the safety and efficacy of oral treprostinil in preventing progression of SSc-associated calcinosis. METHODS: This prospective open-label study enrolled 12 SSc patients meeting 2013 ACR/EULAR classification criteria with confirmed ... Full text Link to item Cite

Concurrent use of capecitabine with radiation therapy and survival in breast cancer (BC) after neoadjuvant chemotherapy.

Journal article Clin Transl Oncol · October 2018 PURPOSE: Capecitabine has been studied as a radiosensitizer, and our study seeks to examine the association of concurrent capecitabine/radiation therapy (RT) on event-free- (EFS) and overall survival (OS) in women with breast cancer (BC) with residual dise ... Full text Link to item Cite

Obesity and survival in the neoadjuvant breast cancer setting: role of tumor subtype in an ethnically diverse population.

Journal article Breast Cancer Res Treat · January 2018 BACKGROUND: Obesity may negatively affect survival in breast cancer (BC), but studies are conflicting, and associations may vary by tumor subtypes and race/ethnicity groups. METHODS: In a retrospective review, we identified 273 women with invasive BC admin ... Full text Link to item Cite

Obesity and survival in the neoadjuvant breast cancer setting: Role of tumor subtype and race.

Journal article Journal of Clinical Oncology · May 20, 2017 e12136 Background: Obesity may adversely influence survival in breast cancer; however, studies are conflicting and limited in the neoadjuvant setting. Results may also vary by tumor subtype and race/ethnicity. Our study seeks to ... Full text Cite

Concurrent use of capecitabine with radiation therapy and survival in breast cancer (BC) after neoadjuvant chemotherapy.

Journal article Journal of Clinical Oncology · May 20, 2017 e12117 Background: Capecitabine has been studied as a radiosensitizer in rectal cancer, but its role in BC is unclear. Our study seeks to examine the association of concurrent capecitabine/radiation therapy (RT) on survival in wo ... Full text Cite

Environmental life cycle information management and acquisition - First experiences and results from field trials

Conference Electronics Goes Green 2004 (Plus): Driving Forces for Future Electronics, Proceedings · 2004 Link to item Cite